Karen Buch Lauritsen “Characterization of immunogenicity of tumor necrosis factor inhibitors in arthritis patients with poorer response to treatment due to gender, obesity and smoking status” (vejledere: Lene Wohlfahrt Dreyer, Salome Kristensen, Kaspar René Nielsen, Christian Enevoldsen, Claus Henrik Nielsen)
Rasmus Westermann “The effects of biological DMARDs on cancer risk in patients with inflammatory arthritis: Incidence, recurrence and mortality” (vejledere: Lene Wohlfahrt Dreyer, René Cordtz, Lene Mellemkjær, Merete Hetland)
Kirsten Skjærbæk Duch "Using big data technologies to identify patients with high risk of serious infections following glucocorticoid treatment in inflammatory rheumatic disease" (vejledere: Lene Wohlfahrt Dreyer, Salome Kristensen, Søren Lundbye-Christensen, Martin Bøgsted, Ole Hejlesen)
Mads Engell Refstrup Sørensen "Risk of diabetes mellitus in patients with giant cell arthritis and polymyalgia rheumatica treated with interleukin-6 inhibitors" (vejledere: Salome Kristensen, Lene Wohlfahrt Dreyer, Bolette Gylden Soussi, Line Uhrenholt)
Bergur Magnussen "Examining cancer-related outcomes and the safety of immune check point inhibitors in Danish patients with rheumatoid arthritis" (vedjledere: Lene Wohlfahrt Dreyer, Salome Kristensen, Lene Mellemkjær, Morten Ladekarl)
Louis Nygaard Pedersen "Improved risk profiling to predict and prevent the development of cardiovascular disease in patients with ANCA-associated vasculitis" (vejledere: Jon Waarst Gregersen, Salome Kristensen, Jeppe Hagstrup Christensen)
Simon Jønck “Exercise-induced cardiac adaptions in rheumatoid arthritis patients during interleukin-6 vs. tumor necrosis factor antibody: a randomised, controlled study (RABEX)” (vejledere: Regitze Højgaard, Lene Wohlfahrt Dreyer, Pil Højgaard, Bente Klarlund)
Janni Maria Pedersen “Lymphocyte activation gene 3 (LAG-3) and its binding partners in arthritis. A "bench-to-bedside - bedside-to-bench” (vejledere: Asbjørn Mohr Drewes, Bent Winding Deleuran, Lene Wohlfahrt Dreyer)
